Presentation at PharmaSynergyRx Event

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your SVNS notes

Solvonis Therapeutics (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, announces that Anthony Tennyson, Chief Executive Officer of the Company, will be presenting Solvonis Therapeutics plc in the Strategy and Growth track at the PharmaSynergyRx 2025 event in London on 27 February 2025.

PharmaSynergyRx brings together over 200 Business Development and C-suite executives, creating a platform for companies pursuing co-developments, partnerships, licensing and commercial deals within the bio-technology industry.

For more information, please visit: https://pharma-synergy-conference.com/pharmasynergy-2025/

www.solvonis.com

X (formerly Twitter)

About Reach announcements

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.